Inovio Pharmaceuticals is trading 6.2% higher at $0.85 on October 22, 2026, with no clear cause identified. - No new company-specific announcement or clear intraday catalyst was identified. The $80,416,101 court judgment, announced October 20, may be difficult to collect given defendants’ financial condition and does not explain today’s rise. - Reuters reported falling Nasdaq futures and rising oil amid renewed AI-spending concerns and Middle East tensions, a risk-off backdrop that runs counter to the gain.